Jan Phillipp Bewersdorf

85PUBLICATIONS
165CO-AUTHORS
Gene and molecular therapyHaematological tumoursRegenerative medicine (incl. stem cells)Metabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (85)

|Sep 13, 2026
Resistance mechanisms and therapeutic strategies after menin inhibitor failure in acute myeloid leukemia.

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 07, 2026
Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis.

|Apr 25, 2026
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.

Pageof 15

Frequent Collaborators

25 joint publications

Rory Shallis

10 joint publications

Amer M Zeidan

8 joint publications

Talha Badar

7 joint publications

Anand Patel